SCHEMBL19620671

SCHEMBL19620671

NC1=C(OS(=O)Cc2ccccc2)C(=O)C(c2ccc3ccccc3n2)O1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HIF1A Q16665 1/20 0.40
KDM4E B2RXH2 2/20 0.30
POLB P06746 1/20 0.30
ESR1 P03372 1/20 0.30
NCF1 P14598 1/20 0.30
NOS2 P35228 1/20 0.30
BACE1 P56817 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20367966 0.81 TOP2A (0.35) MAPTALDH1A1MEN1NPC1RAB9A
SCHEMBL19620621 0.80 MAPT (0.49) MAPTALDH1A1TP53CYP3A4MAPK1
SCHEMBL19620559 0.79 ALDH1A1 (0.41) MAPTALDH1A1MEN1NPC1TP53
SCHEMBL15620101 0.78 MAPT (0.40) MAPTALDH1A1MEN1NPC1TP53
SCHEMBL19620635 0.77 TP53 (0.43) MAPTALDH1A1MEN1NPC1TP53
SCHEMBL19620531 0.76 MAPT (0.39) MAPTALDH1A1TP53CYP3A4MAPK1
SCHEMBL15627599 0.75 KDM4E (0.41) MAPTMEN1RAB9AKMT2AKDM4E
SCHEMBL20367974 0.75 MAPT (0.41) MAPTALDH1A1MEN1MAPK1RAB9A
SCHEMBL19620539 0.75 CYP1A2 (0.33) MAPTALDH1A1CYP3A4KDM4EPOLB
SCHEMBL19620732 0.75 MEN1 (0.33) MAPTALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed